Motilal Oswal's research report on MRF
MRF’s 3QFY26 Adj PAT at INR7.3b was well ahead of our estimates of INR5.5b. This was largely attributed to strong operating performance, with EBITDA margins expanding 550bp YoY to 17.2% (vs. our estimate of 15.3%). We expect MRF to post a 15% earnings CAGR over FY25-28E. However, its RoCE has declined from a recent peak of 13% in FY24 to 10% in FY25 and is likely to improve to 11% by FY28E. Given its sub-par returns, valuations at 24.8x / 22.1x FY27E / FY28E appear expensive. Hence, we reiterate our Sell rating on the stock with a TP of INR129,151 (valuing it at 20x Dec’27E EPS).
Outlook
Given its sub-par returns, valuations at 24.8x / 22.1x FY27E / FY28E appear expensive. Reiterate Sell with a TP of INR 129,151, valued at 20x Dec27E EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.